logo
Plus   Neg
Share
Email

PG&E Reaches $11 Bln Settlement For Wildfire Claims

PG&E Corp. (PCG) reached an $11 billion settlement with entities representing about 85% of insurance claims related to 2017 and 2018 wildfires.

It is the second major settlement of wildfire claims by PG&E, and requires approval by the federal bankruptcy judge overseeing the utility's Chapter 11 case. The company said the claims were based on payments made by insurance companies to individuals and businesses with insurance coverage for wildfire damage.

PG&E said proceedings on the third and final major group of wildfire claims remain pending in federal and state courts.

PG&E had filed for bankruptcy protection in January as it faces up to $30 billion in fire liabilities, including last year's Camp Fire, the deadliest and most destructive wildfire of California's modern history. The Camp Fire, which burned in Paradise, California, last November, killed at least 86 people.

Equipment owned and maintained by the company also started at least 17 of the 21 major wildfires that burned in California in 2017, according to the California Department of Forestry and Fire Protection.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Billionaire Warren Buffett's Berkshire Hathaway reported a profit for the second-quarter that increased 87 percent from last year, as the value of its investment portfolio increased with the stock market. But it took about $10 billion write down on the value of its Precision Castparts aircraft parts unit due to the impact of the COVID-19 pandemic. Operating profit declined 10 percent. Twitter has had preliminary talks with TikTok's Chinese owner ByteDance to buy the U.S. operations of the video-sharing app, the Wall Street Journal reported citing people familiar with the matter. Meanwhile, Microsoft has been the only company so far to say publicly it is pursuing TikTok. Pfizer said Friday it reached a multi-year deal with Gilead Sciences to manufacture and supply Gilead's investigational antiviral remdesivir for COVID-19 patients.
Follow RTT